<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List href="ExameFARMACO252_arquivos/filelist.xml">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Lucas Franco Melchiades</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Lucas Franco Melchiades</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>33</o:TotalTime>
  <o:Created>2023-05-15T19:40:00Z</o:Created>
  <o:LastSaved>2023-05-15T19:40:00Z</o:LastSaved>
  <o:Pages>7</o:Pages>
  <o:Words>1694</o:Words>
  <o:Characters>9660</o:Characters>
  <o:Lines>80</o:Lines>
  <o:Paragraphs>22</o:Paragraphs>
  <o:CharactersWithSpaces>11332</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="ExameFARMACO252_arquivos/themedata.thmx">
<link rel=colorSchemeMapping
href="ExameFARMACO252_arquivos/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="376">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hashtag"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Unresolved Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Link"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1040178053 9 0 511 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	mso-ansi-language:PT-BR;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	mso-ansi-language:PT-BR;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	mso-ansi-language:PT-BR;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	mso-ansi-language:PT-BR;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	mso-ansi-language:PT-BR;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:138154821;
	mso-list-type:hybrid;
	mso-list-template-ids:951747286 -1883315716 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
	{mso-level-text:%1-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l0:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l0:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l0:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l0:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l0:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l0:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l0:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l0:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l1
	{mso-list-id:176892016;
	mso-list-type:hybrid;
	mso-list-template-ids:221025374 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l1:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l1:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l1:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l1:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l1:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l1:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l1:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l1:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l1:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l2
	{mso-list-id:364406459;
	mso-list-type:hybrid;
	mso-list-template-ids:1148328608 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l2:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l2:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l2:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l2:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l2:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l2:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l2:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l2:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l2:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l3
	{mso-list-id:452988582;
	mso-list-type:hybrid;
	mso-list-template-ids:-866585422 67698705 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l3:level1
	{mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l3:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l3:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l4
	{mso-list-id:619335614;
	mso-list-type:hybrid;
	mso-list-template-ids:-1592916646 67698705 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l4:level1
	{mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l4:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l4:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l5
	{mso-list-id:778061623;
	mso-list-type:hybrid;
	mso-list-template-ids:-1915222768 -1231135148 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l5:level1
	{mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@list l5:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l5:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l5:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l5:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l5:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l5:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l5:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l5:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l6
	{mso-list-id:793720410;
	mso-list-type:hybrid;
	mso-list-template-ids:-310236332 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l6:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l6:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l6:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l6:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l6:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l6:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l6:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l6:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l6:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l7
	{mso-list-id:800223879;
	mso-list-type:hybrid;
	mso-list-template-ids:1948281344 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l7:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l7:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l7:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l7:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l7:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l7:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l7:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l7:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l7:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l8
	{mso-list-id:913899823;
	mso-list-type:hybrid;
	mso-list-template-ids:145939406 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l8:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l8:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l8:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l8:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l8:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l8:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l8:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l8:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l8:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l9
	{mso-list-id:981008630;
	mso-list-type:hybrid;
	mso-list-template-ids:1663601840 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l9:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l9:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l9:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l9:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l9:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l9:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l9:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l9:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l9:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l10
	{mso-list-id:1151483384;
	mso-list-type:hybrid;
	mso-list-template-ids:816324562 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l10:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l10:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l10:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l10:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l10:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l10:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l10:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l10:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l10:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l11
	{mso-list-id:1189369261;
	mso-list-type:hybrid;
	mso-list-template-ids:2034146046 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l11:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l11:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l11:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l11:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l11:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l11:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l11:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l11:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l11:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l12
	{mso-list-id:1306200116;
	mso-list-type:hybrid;
	mso-list-template-ids:-1059000688 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l12:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l12:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l12:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l12:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l12:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l12:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l12:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l13
	{mso-list-id:1325814352;
	mso-list-type:hybrid;
	mso-list-template-ids:-1367674104 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l13:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l13:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l13:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l13:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l13:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l13:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l13:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l14
	{mso-list-id:1554612056;
	mso-list-type:hybrid;
	mso-list-template-ids:-305385056 488917158 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l14:level1
	{mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@list l14:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l14:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l14:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l14:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l14:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l14:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l14:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l14:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l15
	{mso-list-id:1663312912;
	mso-list-type:hybrid;
	mso-list-template-ids:1252565680 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l15:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l15:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l15:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l16
	{mso-list-id:1781216881;
	mso-list-type:hybrid;
	mso-list-template-ids:-565309956 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l16:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l16:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l16:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l16:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l16:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l16:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l16:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l16:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l16:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l17
	{mso-list-id:1874686358;
	mso-list-type:hybrid;
	mso-list-template-ids:-268685800 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l17:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l17:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l17:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l17:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l17:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l17:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l17:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l17:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l17:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l18
	{mso-list-id:1929925364;
	mso-list-type:hybrid;
	mso-list-template-ids:1405507782 67698705 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l18:level1
	{mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l18:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l18:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l18:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l18:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l18:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l18:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l18:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l18:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l19
	{mso-list-id:2074622832;
	mso-list-type:hybrid;
	mso-list-template-ids:247089090 483971938 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l19:level1
	{mso-level-text:%1-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l19:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l19:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l19:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l19:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l19:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l19:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l19:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l19:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l20
	{mso-list-id:2094542215;
	mso-list-type:hybrid;
	mso-list-template-ids:-553604136 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l20:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l20:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l20:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l20:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l20:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l20:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l20:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l20:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l20:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
@list l21
	{mso-list-id:2131319837;
	mso-list-type:hybrid;
	mso-list-template-ids:-1683965118 67698711 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l21:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l21:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l21:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:90.0pt;
	text-indent:-9.0pt;}
@list l21:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;}
@list l21:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l21:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:198.0pt;
	text-indent:-9.0pt;}
@list l21:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;}
@list l21:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l21:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:306.0pt;
	text-indent:-9.0pt;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Tabela normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin-top:0cm;
	mso-para-margin-right:0cm;
	mso-para-margin-bottom:8.0pt;
	mso-para-margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:36.0pt;word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal><span lang=PT-BR>1 - Sobre a figura abaixo, responda:</span></p>

<p class=MsoNormal><span lang=PT-BR>a) Que medicamento  este? (0,1)</span></p>

<p class=MsoNormal><span lang=PT-BR>b) Como deve ser usado? Via de
administrao e frequncia de <span class=GramE>uso.(</span>0,3)</span></p>

<p class=MsoNormal><span lang=PT-BR>c) Mecanismo de <span class=GramE>ao.(</span>0,5)</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 16.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 16.0pt 0cm'><span lang=PT-BR
style='background:yellow;mso-highlight:yellow'>IMAGEM DE UMA CAIXA DE <u>CYCLOFEMINA</u></span><u><span
lang=PT-BR><o:p></o:p></span></u></p>

</div>

<p class=MsoNormal><span lang=PT-BR>2 - Sobre a figura abaixo, responda: </span></p>

<p class=MsoNormal><span lang=PT-BR>a) Que medicamento  este? (0,2)</span></p>

<p class=MsoNormal><span lang=PT-BR>b) Quando e como  usado? (0,2)</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-36.0pt;border:none;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span
lang=PT-BR style='background:yellow;mso-highlight:yellow'>IMAGEM DE UMA CAIXA
DE <u>POZATOUNI</u></span><u><span lang=PT-BR><o:p></o:p></span></u></p>

</div>

<p class=MsoNormal><span lang=PT-BR>3 - Uma paciente faz uso regularmente de
Tmisa 20, recebe de um amigo a amostra grtis abaixo (<span class=SpellE>Ginesse</span>)
que contm a mesma <span class=SpellE>comopsio</span>.</span></p>

<p class=MsoNormal><span lang=PT-BR>Responda:</span></p>

<p class=MsoNormal><span lang=PT-BR>a) Tmisa 20 e <span class=SpellE>Ginesse</span>
so intercambiveis? <span class=SpellE>Jusifique</span> sua resposta. (0,4)</span></p>

<p class=MsoNormal><span lang=PT-BR>b) Cite 5 benefcios no anticoncepcionais.
(0,5)</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>c) A paciente
faz uso de <span class=SpellE>fenitona</span> (anticonvulsivante), que
cuidados esta paciente deve ter? Justifique sua resposta. (0,4)</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>4 - Quanto ao medicamento ao lado (<span
class=SpellE>Premarim</span>)</span></p>

<p class=MsoNormal><span lang=PT-BR>Responda:</span></p>

<p class=MsoNormal><span lang=PT-BR>a) Quando e como  usado? (0,2)</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>b) O que so <span
class=SpellE>estrogenos</span> naturais conjugados? (0,2)</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>5 - Paciente em uso de anticoagulante oral
para profilaxia de trombose venosa profunda recorrente, inicia por conta o uso
de AAS para tratamento de artralgia. Poucos dias depois apresenta epistaxe,
hemoptise, hematria e sangramento digestivo. Procura o PSM onde verifica-se TP
elevado (Tempo de Protrombina), recebendo vitamina K 10 mg por via sc.</span></p>

<p class=MsoNormal><span lang=PT-BR>Responda:</span></p>

<p class=MsoNormal><span lang=PT-BR>a) Explique o que aconteceu: (0,2)</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>b) O uso de um
AINE seletivo da COX2 seria melhor neste caso para tratar a <span class=GramE>artralgia?,</span>
Justifique (0,2) </span></p>

</div>

<span lang=PT-BR style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;mso-ansi-language:PT-BR;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='mso-special-character:line-break;
page-break-before:always'>
</span>

<p class=MsoNormal><span lang=PT-BR><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=PT-BR>7 - Assinale verdadeira ou falsa e
justifique as alternativas falsas: (0,1 cada)</span></p>

<p class=MsoNormal><span class=GramE><span lang=PT-BR>(<span
style='mso-spacerun:yes'> </span>)</span></span><span lang=PT-BR> Os
antipsicticos devem ser inicialmente prescritos em monoterapia e apenas aps constatada
a falha deve ser realizada a troca por outro frmaco.</span></p>

<p class=MsoNormal><span class=GramE><span lang=PT-BR>(<span
style='mso-spacerun:yes'> </span>)</span></span><span lang=PT-BR> O <span
class=SpellE>Valproato</span> atua inibindo a sntese e estimulando o
metabolismo de GABA.</span></p>

<p class=MsoNormal><span class=GramE><span lang=PT-BR>(<span
style='mso-spacerun:yes'> </span>)</span></span><span lang=PT-BR> O Ltio
sozinho apresenta como um de seus mecanismos de ao o acumulo de IP, o que impede
a correta sinalizao celular</span></p>

<p class=MsoNormal><span class=GramE><span lang=PT-BR>(<span
style='mso-spacerun:yes'> </span>)</span></span><span lang=PT-BR> O Ltio
sempre pode ser utilizado sozinho na fase depressiva do transtorno bipolar.</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span class=GramE><span
lang=PT-BR>(<span style='mso-spacerun:yes'> </span>)</span></span><span
lang=PT-BR> Devido a possuir um ndice teraputico alto, o Ltio  um frmaco de
utilizao bastante segura.</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Marque a alternativa correta: (0,2 cada)</span></p>

<p class=MsoNormal><span lang=PT-BR>Homem de 43 anos, bancrio, residente em
Pelotas, fumante, relata dor epigstrica do tipo queimadura, nas ltimas
semanas, aliviada com o alimento. O diagnstico confirmado por endoscopia foi
de lcera duodenal e infeco por H. <span class=SpellE>pylori</span>. O mdico
prescreveu Omeprazol e antibiticos.</span></p>

<p class=MsoNormal><span lang=PT-BR>1) O omeprazol foi usado por ser
antagonista H2</span></p>

<p class=MsoNormal><span lang=PT-BR>2) O omeprazol no pode ser dissolvido,
triturado ou fracionado</span></p>

<p class=MsoNormal><span lang=PT-BR>3) Poderia ter sido associado bismuto para
promover a cicatrizao da lcera</span></p>

<p class=MsoNormal><span lang=PT-BR>4) Poderia ter sido usado um <span
class=SpellE><span class=GramE>anti-cido</span></span> para promover a
cicatrizao da lcera</span></p>

<p class=MsoNormal><span lang=PT-BR>ESTAO CORRETOS:<span style='mso-tab-count:
1'> </span></span></p>

<p class=MsoNormal><span lang=PT-BR>a) 1, 2 e 3<span style='mso-tab-count:1'> </span>b)
1, 2 e 4<span style='mso-tab-count:1'> </span>c) 2,3<span
style='mso-tab-count:2'> </span>d) 1,2 <span style='mso-tab-count:
1'> </span></span></p>

<p class=MsoNormal><span lang=PT-BR>e) 1,3<span style='mso-tab-count:1'> </span><span
style='mso-tab-count:1'> </span>f) 2,3,4<span style='mso-tab-count:
1'> </span><span style='mso-spacerun:yes'> </span><span style='mso-tab-count:
1'> </span>g) todos</span></p>

<p class=MsoNormal><span lang=PT-BR><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=PT-BR>Ainda sobre o caso anterior, os
antimicrobianos mais utilizados so</span></p>

<p class=MsoNormal><span lang=PT-BR>1) Penicilina G<span style='mso-tab-count:
2'> </span>2) Amoxicilina<span style='mso-tab-count:2'> </span>3)
Metronidazol</span></p>

<p class=MsoNormal><span lang=PT-BR>4) Gentamicina<span style='mso-tab-count:
2'> </span>5) <span class=SpellE>Claritromicina</span></span></p>

<p class=MsoNormal><span lang=PT-BR>ESTAO CORRETOS:<span style='mso-tab-count:
1'> </span></span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>a) 1, 2 e 3<span
style='mso-tab-count:1'> </span>b) 1, 2 e 5<span style='mso-tab-count:
1'> </span>c) 2,3 e 4<span style='mso-tab-count:1'> </span>d)
2, 3 e 5 <span style='mso-tab-count:1'> </span>g) todos</span></p>

</div>

<span lang=PT-BR style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;mso-ansi-language:PT-BR;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='mso-special-character:line-break;
page-break-before:always'>
</span>

<p class=MsoNormal><span lang=PT-BR><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=PT-BR>Quanto aos frmacos que atuam sobre a
secreo de cido clordrico, MARQUE A RESPOSTA ERRADA:</span></p>

<p class=MsoNormal><span lang=PT-BR>- Em termos de cicatrizao de lceras,
quando recorrente ou com infeco pelo H. <span class=SpellE>pylori</span>, os
inibidores da bomba de prtons e os anti-H2 possuem a mesma eficcia</span></p>

<p class=MsoNormal><span lang=PT-BR>- A <span class=SpellE>metoclopramida</span>
 um frmaco <span class=SpellE><span class=GramE>anti-emtico</span></span> e
tambm pr-cintico, mas tem como importante efeito colateral sndrome
extrapiramidal</span></p>

<p class=MsoNormal><span lang=PT-BR>- <span class=GramE>Ao antagonistas
dopaminrgicos</span> esto entre os frmacos mais potentes e mais utilizados
para tratamento de <span class=SpellE>nuseas</span> e vmitos provocados por
quimioterapia</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>- A
escopolamina  um <span class=SpellE>antimuscarnico</span> muito utilizado
como antiespasmdico</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Quanto aos <span class=SpellE><span
class=GramE>anti-emticos</span></span>:</span></p>

<p class=MsoNormal><span lang=PT-BR>- Os anti-histamnicos so muito potentes,
por isto, teis para vmito provocado por quimioterapia </span></p>

<p class=MsoNormal><span lang=PT-BR>- Os antagonistas dopaminrgicos so muito <span
class=GramE>potentes</span> mas tem muitos efeitos colaterais</span></p>

<p class=MsoNormal><span lang=PT-BR>- Os antagonistas dopaminrgicos so teis
para vmitos em gestantes</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>- Os
antagonistas da serotonina em receptor 5HT3 so os mais potentes e com menos
efeitos colaterais</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Quanto aos laxantes:</span></p>

<p class=MsoNormal><span lang=PT-BR>- Os laxantes osmticos <span class=GramE>tem</span>
latncia muito longa </span></p>

<p class=MsoNormal><span lang=PT-BR>- Os <span class=SpellE>opiides</span>
provocam <span class=SpellE>diarria</span> </span></p>

<p class=MsoNormal><span lang=PT-BR>- Sene e <span class=SpellE>cscara</span>
sagrada, por serem naturais, no provocam atonia intestinal nem dependncia </span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>- Os <span
class=SpellE>enemas</span> contm laxantes osmticos/salinos</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Com relao aos anticoncepcionais: </span></p>

<p class=MsoNormal><span lang=PT-BR>- Os produtos naturais so os mais
utilizados </span></p>

<p class=MsoNormal><span lang=PT-BR>- Os contraceptivos injetveis so
compostos de estrgenos</span></p>

<p class=MsoNormal><span lang=PT-BR>- A miniplula  a teraputica mais eficaz </span></p>

<p class=MsoNormal><span lang=PT-BR>- O DIU contm somente estrgeno </span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>- A inibio da
ovulao, na teraputica combinada, se d por supresso de RH-FSH e RH-LH</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Anticoncepcional e respectivo hormnio:<span
style='mso-tab-count:1'> </span><span style='mso-tab-count:5'> </span></span></p>

<p class=MsoNormal><span lang=PT-BR>1- Implante SC: somente estrgeno<span
style='mso-tab-count:1'> </span>2- Adesivo <span class=SpellE>transdrmico</span>:
<span class=SpellE>estrgeno+progestgeno</span></span></p>

<p class=MsoNormal><span lang=PT-BR>3- IM mensal: somente estrgeno<span
style='mso-tab-count:1'> </span>4- Anel vaginal: <span class=SpellE>estrgeno+progestgeno</span><span
style='mso-tab-count:1'> </span></span></p>

<p class=MsoNormal><span lang=PT-BR>ESTO CERTAS:<span
style='mso-spacerun:yes'> </span>1 e 2<span style='mso-tab-count:2'> </span>2
e 3<span style='mso-tab-count:2'> </span>1, 2 e 3<span
style='mso-tab-count:2'> </span></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:36.0pt'><span
lang=PT-BR>1 e 3<span style='mso-tab-count:2'> </span>2 e 4<span
style='mso-tab-count:2'> </span>Todas</span></p>

<p class=MsoNormal><span lang=PT-BR>Em caso de paciente diabtica controlado
deve-se:<span style='mso-tab-count:4'> </span></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l18 level1 lfo6'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>1)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span class=GramE><span
lang=PT-BR>Contra-indicar</span></span></span><span lang=PT-BR> o uso de
anticoncepcional<span style='mso-tab-count:1'> </span><span
style='mso-tab-count:1'> </span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l18 level1 lfo6'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>2)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Usar anticoncepcional de alta
dosagem</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l18 level1 lfo6'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>3)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>No h restries especiais
para diabticas<span style='mso-tab-count:1'> </span></span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l18 level1 lfo6'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>4)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Usar anticoncepcional de baixa
dosagem</span></p>

<p class=MsoNormal><span lang=PT-BR>ESTO CERTAS:<span
style='mso-spacerun:yes'> </span>1 e 2<span style='mso-tab-count:1'> </span>2
e 3<span style='mso-tab-count:1'> </span>1, 2 e 3<span style='mso-tab-count:
1'> </span><span style='mso-tab-count:1'> </span></span></p>

<p class=MsoNormal style='margin-left:72.0pt'><span lang=PT-BR>3<span
style='mso-tab-count:1'> </span>4<span style='mso-tab-count:1'> </span>Nenhuma</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR><o:p>&nbsp;</o:p></span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>So efeitos benficos comprovados da
Terapia de Reposio Hormonal:<span style='mso-tab-count:2'> </span></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l5 level1 lfo7'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>1)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Melhora cardiovascular<span
style='mso-tab-count:1'> </span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l5 level1 lfo7'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>2)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Melhora da pele e mucosas </span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l5 level1 lfo7'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>3)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Preveno de Alzheimer</span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l5 level1 lfo7'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>4)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Osteoporose<span
style='mso-tab-count:4'> </span><span
style='mso-tab-count:4'> </span></span></p>

<p class=MsoNormal><span lang=PT-BR>ESTO CERTAS:<span
style='mso-spacerun:yes'> </span>1 e 2<span style='mso-tab-count:2'> </span>2
e 3<span style='mso-tab-count:2'> </span>1, 2 e 3</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR><span
style='mso-tab-count:2'> </span>1 e 3<span
style='mso-tab-count:2'> </span>2 e 4<span style='mso-tab-count:
2'> </span>Todas</span></p>

</div>

<p class=MsoNormal><span class=SpellE><span class=GramE><span lang=PT-BR>Contra-indicao</span></span></span><span
lang=PT-BR> para Terapia de Reposio Hormonal:<span style='mso-tab-count:4'> </span></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l14 level1 lfo8'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>1)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>CA de mama<span
style='mso-tab-count:2'> </span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l14 level1 lfo8'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>2)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Hepatopatias</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l14 level1 lfo8'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>3)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Infarto do miocrdio</span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l14 level1 lfo8'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>4)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Osteoporose</span></p>

<p class=MsoNormal><span lang=PT-BR>ESTO CERTAS:<span
style='mso-spacerun:yes'> </span>1 e 2<span style='mso-tab-count:2'> </span>2
e 3<span style='mso-tab-count:2'> </span>1, 2 e 3</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR><span
style='mso-tab-count:2'> </span>1 e 3<span
style='mso-tab-count:2'> </span>2 e 4<span style='mso-tab-count:
2'> </span>Todas</span></p>

</div>

<p class=MsoNormal><span class=SpellE><span lang=PT-BR>Anti-cido</span></span><span
lang=PT-BR> que pode provocar constipao:<span style='mso-tab-count:1'> </span><span
style='mso-tab-count:5'> </span></span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l6 level1 lfo9;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Hidrxido de Al<span
style='mso-tab-count:1'> </span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l6 level1 lfo9;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Bicarbonato de Na<span
style='mso-tab-count:1'> </span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l6 level1 lfo9;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Hidrxido de Mg<span
style='mso-tab-count:1'> </span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l6 level1 lfo9;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Trissilicato de Mg</span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l6 level1 lfo9;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>e)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Cimetidina</span></p>

</div>

<p class=MsoNormal><span class=SpellE><span lang=PT-BR>Anti-cido</span></span><span
lang=PT-BR> que tambm pode ser usado como laxante:<span style='mso-tab-count:
4'> </span></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l10 level1 lfo10'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Hidrxido de Al<span
style='mso-tab-count:1'> </span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l10 level1 lfo10'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Bicarbonato de Na<span
style='mso-tab-count:1'> </span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l10 level1 lfo10'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Hidrxido de Mg<span
style='mso-tab-count:2'> </span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l10 level1 lfo10'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Trissilicato de Mg<span
style='mso-tab-count:1'> </span></span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l10 level1 lfo10'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>e)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Cimetidina</span></p>

<p class=MsoNormal><span lang=PT-BR>MARQUE A RESPOSTA ERRADA:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l11 level1 lfo11'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>A <span class=SpellE>metoclopramida</span>
 um frmaco <span class=SpellE><span class=GramE>anti-emtico</span></span> e
tambm pr-cintico, mas tem como importante efeito colateral sndrome
extrapiramidal</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l11 level1 lfo11'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=GramE><span lang=PT-BR>Ao
antagonistas dopaminrgicos</span></span><span lang=PT-BR> esto entre os
frmacos mais potentes e mais utilizados para tratamento de <span class=SpellE>nuseas</span>
e vmitos provocados por quimioterapia</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l11 level1 lfo11'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>A escopolamina  um <span
class=SpellE>antimuscarnico</span> muito utilizado como antiespasmdico</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l11 level1 lfo11;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Para tratamento de nuseas da
gestante, todos os anti-histamnicos anti-H1 podem ser usados por serem
frmacos considerados seguros.</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Quanto  vitamina K:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l20 level1 lfo12'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR> sintetizada no intestino</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l20 level1 lfo12'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR> usada para reverter a ao
dos anticoagulantes orais</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l20 level1 lfo12'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR> <span class=SpellE><span
class=GramE>contra-indicada</span></span> em recm nascidos </span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l20 level1 lfo12'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>A forma mais usada so os
derivados K3 </span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l20 level1 lfo12;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>e)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Tem poucos efeitos colaterais</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Frmaco utilizado nas fases iniciais da
Doena de Alzheimer, cujo mecanismo de ao envolve melhora na sinalizao colinrgica:</span></p>

<p class=MsoNormal><span lang=PT-BR>a) Memantina<span style='mso-tab-count:
2'> </span>b) Levodopa<span style='mso-tab-count:2'> </span>c)
<span class=SpellE>Donepezil</span></span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>d) Fluoxetina<span
style='mso-tab-count:2'> </span>e) <span class=SpellE>Selegilina</span></span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Com relao aos antidepressivos, assinale a
alternativa correta:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l16 level1 lfo13'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Os inibidores seletivos da
recaptao de serotonina apresentam como efeito adverso o risco de causarem a
chamada Reao do Queijo</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l16 level1 lfo13'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>A <span class=SpellE>Paroxetina</span>
apresenta um metablito ativo que permanece no organismo por vrios dias, o que
torna necessrio um maior tempo de intervalo na troca por outro antidepressivo</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l16 level1 lfo13'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Os inibidores irreversveis da
MAO so frmacos muito utilizados na atualidade devido a apresentarem poucos
efeitos adversos e interaes medicamentosas.</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l16 level1 lfo13'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Nas primeiras semanas de
utilizao  comum o aparecimento de alguns sintomas como diminuio da
ansiedade e perda de peso.</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l16 level1 lfo13;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>e)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Frmacos antagonistas dos
receptores 5HT2, como a <span class=SpellE>Mirtazapina</span> so bons
antidepressivos e so boa escolha para pacientes com insnia.</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Qual a justificativa farmacolgica para o
uso de antidepressivos nos controles de ansiedade?</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l1 level1 lfo14'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Os antidepressivos so
depressores do sistema nervoso central</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l1 level1 lfo14'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Altas doses de antidepressivos
dessensibilizam receptores serotoninrgicos 5HT2</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l1 level1 lfo14'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Devido ao efeito adverso em
receptores adrenrgicos</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l1 level1 lfo14'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Somente inibidores da MAO so
utilizados no manejo da ansiedade</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l1 level1 lfo14;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>e)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>antidepressivos no so usados
na ansiedade</span></p>

</div>

<span lang=PT-BR style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;mso-ansi-language:PT-BR;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='mso-special-character:line-break;
page-break-before:always'>
</span>

<p class=MsoNormal><span lang=PT-BR><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=PT-BR>Marque alternativa correta:</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l9 level1 lfo15'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Carbamazepina</span></span><span
lang=PT-BR> atua bloqueando os canais de Na+, sendo um frmaco de escolha para
crise de ausncia.</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l9 level1 lfo15'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Fenitoina</span></span><span
lang=PT-BR>  um frmaco com ndice teraputico baixo e o mecanismo de ao  o
bloqueio de canal de clcio voltagem dependente.</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l9 level1 lfo15'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>No estado do mal epilptico o
frmaco de escolha  o <span class=SpellE>etossuximida</span>.</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l9 level1 lfo15'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Valproato</span></span><span
lang=PT-BR> de sdio  utilizado tambm para tratamento de transtorno bipolar e
um dos mecanismos de ao  o bloqueio de canais Na+ voltagem-dependente.</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l9 level1 lfo15;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>e)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Etossuximida</span></span><span
lang=PT-BR>  a primeira escolha nas crises convulsivas <span class=SpellE>clnico</span>-tnicas,
e seu mecanismo de ao consiste no bloqueio dos canais de Na+
voltagem-dependente.</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>AFS, 70 anos, viva, recentemente teve que
cuidar do filho doente, durante vrios dias no hospital. Devido a esta
situao, comeou apresentar dificuldade para iniciar sono, passando vrias
horas se mexendo na cama antes de iniciar o sono.</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l8 level1 lfo16'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Melhor medicamento <span
class=GramE>pra</span> este paciente  um Diazepam devido a sua farmacocintica</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l8 level1 lfo16'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Melhor medicamento para este
paciente  um Diazepam devido a sua idade</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l8 level1 lfo16'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Melhor medicamento para este
paciente  o <span class=SpellE>Alprazolam</span> devido  baixa probabilidade
de dependncia</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l8 level1 lfo16;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Melhor medicamento para este
paciente  um fenobarbital devido a segurana de uso em idosos.</span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>A utilizao de __________ <span
class=SpellE>na</span> ansiedade generalizada  explicada bioqumica e
farmacologicamente pela ____________ de receptores________ por isto 
necessrio a utilizao de doses ______________ por ____________ semana(s) antes
da melhora clnica. Desta forma justifica-se o uso de _______________ para
tratamento agudo. (0,1 cada)</span></p>

<p class=MsoNormal style='text-indent:36.0pt'><span lang=PT-BR>A sequncia que
completa corretamente o enunciado acima :</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l2 level1 lfo17'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Alprazolam</span></span><span
lang=PT-BR>, <span class=SpellE>agonismo</span>, GABA A, baixas, vrias, dois
benzodiazepnicos</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l2 level1 lfo17'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span class=GramE><span
lang=PT-BR>Benzodiazepinicos</span></span></span><span class=GramE><span
lang=PT-BR> ,</span></span><span lang=PT-BR> <span class=SpellE>agonismo</span>,
GABA A, maiores, 4 (quatro), <span class=SpellE>buspirona</span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l2 level1 lfo17'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Antidepressivos,
dessensibilizao, 5-HT2, baixas, 1 (uma), <span class=SpellE>escitalopram</span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l2 level1 lfo17'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Escitalopram</span></span><span
lang=PT-BR>, dessensibilizao, 5HT2, maiores, vrias, <span class=SpellE>alprazolam</span></span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l2 level1 lfo17;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>e)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Alprazolam</span></span><span
lang=PT-BR>, antagonismo, GABA A, baixas,1 (uma), <span class=SpellE>escitalopram</span></span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Relacione as assertivas com os respectivos
antipsicticos: (0,1 cada)</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l12 level1 lfo18'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Maior correlao com elevao
da prolactina<span style='mso-tab-count:2'> </span>(<span
style='mso-tab-count:1'> </span>) <span class=SpellE>Decanoato</span>
de <span class=SpellE>Haloperidol</span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l12 level1 lfo18'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Agonista parcial dos receptores
D2<span style='mso-tab-count:2'> </span><span style='mso-tab-count:
2'> </span>(<span style='mso-tab-count:1'> </span>)
<span class=SpellE>Clozapina</span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l12 level1 lfo18'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Risco de agranulocitose<span
style='mso-tab-count:3'> </span><span
style='mso-tab-count:2'> </span>(<span style='mso-tab-count:
1'> </span>) <span class=SpellE>Risperidona</span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l12 level1 lfo18'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Maior risco de SEP (<span
class=SpellE>Sindrome</span> extrapiramidal)<span style='mso-tab-count:2'> </span>(<span
style='mso-tab-count:1'> </span>) <span class=SpellE>Clorpromazina</span></span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l12 level1 lfo18;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>e)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Medicamento de deposito<span
style='mso-tab-count:3'> </span><span
style='mso-tab-count:2'> </span>(<span style='mso-tab-count:
1'> </span>) <span class=SpellE>Aripiprazol</span></span></p>

</div>

<span lang=PT-BR style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;mso-ansi-language:PT-BR;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='mso-special-character:line-break;
page-break-before:always'>
</span>

<p class=MsoNormal><span lang=PT-BR><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=PT-BR>Com relao aos antivirais, relacione: (0,1
cada)</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l17 level1 lfo19'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Interage diretamente com a DNA
polimerase viral, bloqueando o local de ligao</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l17 level1 lfo19'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Seletividade de ao depende da
sua interao com duas protenas virais distintas: HSV <span class=SpellE>timidinacinase</span>
e DNA-polimerase.</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l17 level1 lfo19'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Bloqueia o <span class=SpellE>desencapsulamento</span>
do genoma viral e a transferncia desse para a clula hospedeira.</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l17 level1 lfo19'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Bloqueia a fuso entre a
membrana celular e o envoltrio viral, inibindo a entrada do vrus na clula.</span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l17 level1 lfo19'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>e)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Inibe os vrus da <span
class=SpellE>Inluenza</span> A e B, possuindo boa biodisponibilidade oral e
fcil administrao.</span></p>

<p class=MsoNormal><span lang=PT-BR>(<span style='mso-tab-count:1'> </span>)
Aciclovir<span style='mso-tab-count:1'> </span>(<span
style='mso-tab-count:1'> </span>) <span class=SpellE>Foscarnete</span><span
style='mso-tab-count:1'> </span>(<span style='mso-tab-count:1'> </span>)
<span class=SpellE>Oseltamivir</span><span style='mso-tab-count:1'> </span></span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;mso-border-bottom-alt:solid windowtext .75pt;
padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><span lang=PT-BR>(<span
style='mso-tab-count:1'> </span>) <span class=SpellE>Amantadina</span><span
style='mso-tab-count:1'> </span>(<span style='mso-tab-count:1'> </span>)
<span class=SpellE>Doconasol</span></span></p>

</div>

<p class=MsoNormal><span class=SpellE><span lang=PT-BR>Relcione</span></span><span
lang=PT-BR> as colunas: (0,1 cada)</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l21 level1 lfo20'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>a)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Neurotransmissor excitatrio<span
style='mso-tab-count:1'> </span>(<span style='mso-tab-count:1'> </span>)
Capacidade de alterao morfolgica em resposta a<span style='mso-tab-count:
5'> </span><span
style='mso-tab-count:1'> </span>estmulos ambientais ou interno</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l21 level1 lfo20'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>b)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Neuroplasticidade<span
style='mso-tab-count:3'> </span>(<span
style='mso-tab-count:1'> </span>) Pode diminuir ou aumentar a
liberao de<span style='mso-tab-count:1'> </span><span style='mso-tab-count:
5'> </span><span
style='mso-tab-count:1'> </span>neurotransmissor</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l21 level1 lfo20'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>c)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Neurotransmissor Inibitrio<span
style='mso-tab-count:2'> </span>(<span style='mso-tab-count:1'> </span>)
Aumenta o fluxo de Cl<sup>- </sup>para dentro do neurnio</span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l21 level1 lfo20;border:none;mso-border-bottom-alt:
solid windowtext .75pt;padding:0cm;mso-padding-alt:0cm 0cm 1.0pt 0cm'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>d)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Ao em receptores <span
class=SpellE>pr-sinapticos</span><span style='mso-tab-count:1'> </span>(<span
style='mso-tab-count:1'> </span>) Aumenta a permeabilidade ao Na<sup>+</sup></span></p>

</div>

<p class=MsoNormal><span lang=PT-BR>Com relao aos frmacos usados no
tratamento do Parkinson, relacione o frmaco com seu respectivo mecanismo de
ao: (0,1 cada)</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l0 level1 lfo22'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>1-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Carbidopa</span></span><span
lang=PT-BR><span style='mso-tab-count:2'> </span>(<span
style='mso-tab-count:1'> </span>) Inibidor da COMT</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l0 level1 lfo22'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>2-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=PT-BR>Levodopa<span style='mso-tab-count:
2'> </span>(<span style='mso-tab-count:1'> </span>)
Agonista Dopaminrgico</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;mso-add-space:
auto;text-indent:-18.0pt;mso-list:l0 level1 lfo22'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>3-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Entacapona</span></span><span
lang=PT-BR><span style='mso-tab-count:2'> </span>(<span
style='mso-tab-count:1'> </span>) Inibidor da DOPA-descarboxilase</span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:18.0pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l0 level1 lfo22'><![if !supportLists]><span
lang=PT-BR style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>4-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=SpellE><span lang=PT-BR>Bromocriptina</span></span><span
lang=PT-BR><span style='mso-tab-count:1'> </span>(<span
style='mso-tab-count:1'> </span>) Precursor da Dopamina</span></p>

</div>

</body>

</html>
